Nantahala Capital Management LLC Takes $26.23 Million Position in IMAX Corporation $IMAX

Posted by Geri Gentry on Aug 29th, 2026

Nantahala Capital Management LLC purchased a new position in shares of IMAX Corporation (NYSE:IMAX – Free Report) in the second quarter, HoldingsChannel.com reports. The fund purchased 658,009 shares of the company’s stock, valued at approximately $26,228,239. IMAX comprises 0.0% of Nantahala Capital Management LLC’s holdings, making the stock its 24th largest position.

Several other large investors have also made changes to their positions in IMAX. Caitong International Asset Management Co. Ltd increased its stake in IMAX by 28.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,489 shares of the company’s stock valued at $55,000 after acquiring an additional 332 shares during the last quarter. ProShare Advisors LLC raised its position in IMAX by 6.8% during the fourth quarter. ProShare Advisors LLC now owns 8,000 shares of the company’s stock valued at $296,000 after purchasing an additional 511 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in IMAX by 0.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 108,781 shares of the company’s stock worth $4,021,000 after purchasing an additional 546 shares during the last quarter. Quarry LP lifted its stake in IMAX by 166.8% during the fourth quarter. Quarry LP now owns 875 shares of the company’s stock worth $32,000 after purchasing an additional 547 shares during the last quarter. Finally, State of Wyoming boosted its holdings in shares of IMAX by 7.6% in the 1st quarter. State of Wyoming now owns 7,910 shares of the company’s stock valued at $301,000 after purchasing an additional 562 shares in the last quarter. Institutional investors and hedge funds own 93.51% of the company’s stock.

Trending Headlines about IMAX

Here are the key news stories impacting IMAX this week:

Positive Sentiment: The Odyssey is returning to IMAX screens in India after being displaced by Toxic, while its London BFI IMAX engagement has been extended. The developments point to strong audience demand and could support premium-format box-office revenue. The Odyssey returns in India The Odyssey London extension
Positive Sentiment: Netflix’s upcoming Cliff Booth film is set for an IMAX release, adding another high-profile title to the company’s pipeline. A first Japanese IMAX film, Godzilla Minus Zero, is also scheduled for November, potentially broadening international content demand. Netflix IMAX release Godzilla Minus Zero IMAX release
Positive Sentiment: A theater in Indiana is marking its 30th anniversary with an IMAX laser-projection upgrade, supporting demand for higher-quality systems and potential installation-related revenue. Zacks also characterizes IMAX as a strong momentum stock. IMAX laser upgrade Zacks momentum analysis
Neutral Sentiment: IMAX says it remains open to a sale, but no major buyers have emerged despite record box-office performance and substantial stock appreciation. The lack of a suitor removes a potential takeover catalyst, while continued independence leaves the company focused on organic growth. CNBC IMAX sale article
Negative Sentiment: Insider Kenneth Ian Weissman sold 8,000 shares for approximately $436,000, reducing his position by 22.1%. The sale may weigh on sentiment, particularly after the stock’s strong rally, although it does not by itself demonstrate weakening fundamentals. IMAX insider sale

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on IMAX. Weiss Ratings upgraded IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, July 16th. Wall Street Zen downgraded IMAX from a “buy” rating to a “hold” rating in a research report on Saturday, August 22nd. Seaport Research Partners reaffirmed a “buy” rating and issued a $50.00 price objective on shares of IMAX in a research note on Wednesday, June 24th. Rosenblatt Securities reiterated a “buy” rating and issued a $60.00 target price on shares of IMAX in a research report on Wednesday, August 19th. Finally, The Goldman Sachs Group reissued a “neutral” rating and set a $42.00 target price on shares of IMAX in a research note on Thursday, July 23rd. Ten research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $52.36.

View Our Latest Stock Analysis on IMAX

Insider Transactions at IMAX

In related news, CEO Richard L. Gelfond sold 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $53.23, for a total value of $5,323,000.00. Following the completion of the transaction, the chief executive officer owned 665,002 shares in the company, valued at $35,398,056.46. This trade represents a 13.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Natasha Fernandes sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $54.63, for a total transaction of $1,092,600.00. Following the completion of the transaction, the chief financial officer owned 35,596 shares of the company’s stock, valued at approximately $1,944,609.48. This trade represents a 35.97% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 484,757 shares of company stock worth $25,513,021. Insiders own 20.55% of the company’s stock.

IMAX Stock Down 2.8%

NYSE IMAX opened at $50.47 on Friday. The company has a market cap of $2.77 billion, a price-to-earnings ratio of 70.10, a price-to-earnings-growth ratio of 1.66 and a beta of 0.38. IMAX Corporation has a twelve month low of $28.14 and a twelve month high of $55.57. The business’s fifty day moving average is $45.55 and its 200 day moving average is $40.74.

IMAX (NYSE:IMAX – Get Free Report) last issued its earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. The business had revenue of $102.84 million during the quarter, compared to analysts’ expectations of $96.09 million. IMAX had a return on equity of 15.47% and a net margin of 9.84%.The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.26 EPS. On average, research analysts anticipate that IMAX Corporation will post 1.49 earnings per share for the current fiscal year.

About IMAX

(Free Report)

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.